Risk factors of iatrogenic spinal cord injury in Spinal surgery: A multicenter retrospective study

International Journal of Neuroscience

Volumn 122, Issue 10, 2012, Pages 606-610

  Chen, Qi ^a   Li, Feng ^a   Wu, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Logistic analysis; Relevant factors; Spinal surgery

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SPINAL CORD INJURY; SPINE SURGERY; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL CORD INJURIES; SPINE;

EID: 84866353987     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.700660     Document Type: Article

References (23)

1. Alcanyis-Alberola M, Giner-Pascual M, Salinas-Huertas S, Guti'errez-Delgado M. Iatrogenic spinal cord injury: An observational study. Spinal Cord. 2011;49(12):1188-92.
2. Botelho RV, Daniel JW, Boulosa JL, Colli BO, Farias Rde L, Moraes OJ, Pimenta WE Jr, Ribeiro CH, Ribeiro FR, Taricco MA, Carvalho MV, Bernardo WM. Effectiveness of methylprednisolone in the acute phase of spinal cord injuries: A systematic review of randomized controlled trials. Rev Assoc Med Bras. 2009;55(6):729-37.
3. Bacher T, Schiltenwolf M, Niethard FU, Paeslack V. The risk of paraplegia through medical treatment. Spinal Cord. 1999;37(3):172-82.
4. Chalmers J. The 1999 WHO-ISH guidelines for the management of hypertension. Med J Aust. 1999;171(9):458-9.
5. ClarkMJ Jr, Sterrett JJ, Carson DS. Diabetes guidelines: A summary and comparison of the recommendations of the American diabetes association, veterans health administration, and American association of clinical endocrinologists. Clin Ther. 2000;22(8):899-910; discussion 898.
6. Steven C. Kirshblum, Stephen P. Burns, Fin Biering-Sorensen, Donovan W, Graves DE, Jha A, Johansen M, Jones L, Krassioukov A,MulcaheyMJ, Schmidt-Read M,Waring W. International standards for neurological classification of spinal cord injury (Revised 2011) [J]. J Spinal cordMed. 2011;34(6):535-46.
7. Wilson A, Shehadeh LA, YuH,Webster KA. Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics. 2010;11:229-42.
8. Nakamura M, Raghupathi R, Merry DE, Scherbel U, Saatman KE, Mcintosh TK. Overexpression of Bcl-2 is neuroprotective after experimental brain injury in transgenic mice. J CompNeurol. 1999;412(4):681-92.
9. Yune TY, Park HG, Lee JY, Oh TH. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J Neurotrauma. 2008;25(9):1121-31.
10. Howard S, Bottino C, Brooke S,Cheng E, Giffard RG, Sapolsky R. Neuroprotective effects of bcl-2 overexpression in hippocampal cultures: Interactions with pathways of oxidative damage. J Neurochem. 2002; 83(4):914-23.
11. Ouyang YB, Giffard RG. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium. 2004; 36(3-4):303-11.
12. Haldar S, Jena N, Croce CM. Antiapoptosis potential of Bcl-2 oncogene by dephosphorylation. Biochem Cell Biol. 1994;72(11-12):455-62.
13. Hanson CJ, Bootman MD, Distelhorst CW, Wojcikiewicz RJ, Roderick HL. Bcl-2 suppresses Ca2+ release through inositol 1,4,5-trisphosphate receptors and inhibits Ca2+ uptake by mitochondria without affecting ER calcium store content. Cell Calcium. 2008;44(3):324-38.
14. Bjorling DE, BeckmanM, Clayton MK, Wang ZY. Modulation of nerve growth factor in peripheral organs by estrogen and progesterone. Neuroscience. 2002;110:155-67.
15. Sipski ML, Jackson AB, G'omez-Mar'in O, Estores I, Stein A. Effects of gender on neurologic and functional recovery after spinal cord injury. Arch Phys Med Rehabil. 2004;85(11): 1826-36.
16. Cheshire WP, Santos CC, Massey EW, Howard JF Jr. Spinal cord infarction: etiology and outcome. J Neurol. 1996;47: 321-30.
17. Van Gieson EJ, Murfee WL, Skalak TC, Price RJ. Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Circ Res. 2003;92(8): 929-36.
18. Campbell JH, Tachas G, Black MJ, Cockerill G, Campbell GR. Molecular biology of vascular hypertrophy. Basic Res Cardiol. 1991;86(1) 1:3-11.
19. Owens GK, Geisterfer AA, Yang YW, Komoriya A. Transforming growth factor-beta induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988;107(2):771-80.
20. Tator CH. Experimental and clinical studies of the pathophysiology and management of acute spinal cord injury. J Spinal Cord Med. 1996;19(4):206-14.
21. Kayner MY, Hanci M, Kafadar A, Gumuştaş K, Belce A, Ciplak N. The effect of duration of compression on lipid peroxidation after experimental spinal cord injury. Neurosurg Rev. 1998;21(2-3):117-20.
22. Aoyama T, Hida K, Akino M, Yano S, Iwasaki Y, Saito H. Ultra-early MRI showing no abnormality in a fall victim presenting with tetraparesis. Spinal Cord. 2007;45: 695-9.
23. Delank KS, Delank HW, Konig DP, Popken F, F urderer S, Eysel P. Iatrogenic paraplegia in spinal surgery. Arch Orthop Trauma Surg. 2005;125(1):33-41.